Fallopian Tube Carcinoma

• CLINICAL_TRIALS trial_result · 2017-10-25
  Clinical Trial Update: (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma [Phase 2]

  Phase 2 trial update for platinum-resistant/refractory, paclitaxel-pretreated recurrent ovarian and peritoneal carcinoma; study terminated w…

• CLINICAL_TRIALS withdrawal · 2017-07-14
  Clinical Trial Update: Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy [NA]

  A clinical trial evaluating oregovomab with or without cyclophosphamide in Stage III/IV ovarian epithelial cancer, fallopian tube cancer, or…

• CLINICAL_TRIALS trial_result · 2016-12-14
  Clinical Trial Update: Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors [Phase 2]

  Phase 2 trial update on belinostat for advanced ovarian epithelial cancer, primary peritoneal cancer, fallopian tube cancer, and ovarian low…

• CLINICAL_TRIALS trial_result · 2014-07-17
  Clinical Trial Update: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]

  Phase 2 clinical trial update for A6 in treating persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary perito…

• CLINICAL_TRIALS trial_result · 2014-01-08
  Clinical Trial Update: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Phase 1]

  Phase 1 study evaluating lenalidomide (Revlimid) in combination with pegylated liposomal doxorubicin (Doxil) and bevacizumab (Avastin) in pl…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2013-12-13
  Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]

  Phase 2 trial update for Paclitaxel albumin-stabilized nanoparticle formulation in recurrent or persistent ovarian epithelial cancer, fallop…

• CLINICAL_TRIALS trial_result · 2013-05-10
  Clinical Trial Update: Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study [NA]

  A feasibility study on hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer was terminated; results were posted in 2013.

• CLINICAL_TRIALS trial_result · 2012-12-13
  Clinical Trial Update: Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]

  Phase 2 trial evaluating sorafenib with or without paclitaxel and carboplatin for recurrent ovarian, fallopian tube, or primary peritoneal c…

• CLINICAL_TRIALS trial_result · 2012-10-19
  Clinical Trial Update: A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer [Phase 2]

  A Phase 2 trial update evaluating intravenous denileukin diftitox in stage III/IV ovarian cancer (epithelial ovarian cancer, extraovarian pe…